Time-dependent changes in biochemical bone markers and serum cholesterol in ovariectomized rats: Effects of raloxifene HCl, tamoxifen, estrogen, and alendronate

Bone

Volumn 18, Issue 6, 1996, Pages 621-627

  Frolik, Charles A ^a   Bryant, H U ^a   Black, E C ^a   Magee, D E ^a   Chandrasekhar, S ^a  

^a ELI LILLY AND COMPANY   (United States)

Author keywords

Bisphosphonate; Bone markers; Estrogen; Raloxifene HCl; SERM; Tamoxifen

Indexed keywords

ALENDRONIC ACID; BIOCHEMICAL MARKER; BISPHOSPHONIC ACID DERIVATIVE; CHOLESTEROL; ESTROGEN; ETHINYLESTRADIOL; OSTEOCALCIN; RALOXIFENE; TAMOXIFEN;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BONE ATROPHY; BONE METABOLISM; BONE TURNOVER; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DRUG EFFECT; DRUG EFFICACY; FEMALE; HYPOCHOLESTEROLEMIA; NONHUMAN; ORAL DRUG ADMINISTRATION; OSTEOLYSIS; OVARIECTOMY; POSTMENOPAUSE OSTEOPOROSIS; RAT; URINALYSIS; UTERUS;

EID: 0030176408     PISSN: 87563282     EISSN: None     Source Type: Journal    
DOI: 10.1016/8756-3282(96)00085-3     Document Type: Article

References (50)

1. 1. Archer, D. F., Pickar, J. H., and Bottiglioni, F. Bleeding patterns in postmenopausal women taking continuous combined or sequential regimens of conjugated estrogens with medroxyprogesterone acetate. Menopause Study Group. Obstet Gynecol 83:686-692; 1994.
2. 2. Black, D., Duncan, A., and Robins, S. P. Quantitative analysis of the pyridinium crosslinks of collagen in urine using ion-paired reversed-phase high-performance liquid chromatography. Anal Biochem 169:197-203; 1988.
3. 3. Black, D., Farquharson, C., and Robins, S. P. Excretion of pyridinium cross-links of collagen in ovariectomized rats as urinary markers for increased bone resorption. Calcif Tissue Int 44:343-347; 1989.
4. 4. Black, L. J., Jones, C. D., and Falcone, J. F. Antagonism of estrogen action with a new benzothiophene derived antiestrogen. Lite Sci 32:1031-1036; 1983.
5. 5. Black, L. J., Sato, M., Rowley, E. R., Magee, D. E., Bekele, A., Williams, D. C., Cullinan, G. J., Bendele, R., Kauffman, R. F., Bensch, W. R., Frolik, C. A., Termine, J. D., and Bryant, H. U. Raloxifene (LY 139481 HCl) prevents bone loss and reduces serum cholesterol without causing uterine hypertrophy in ovariectomized rats. J Clin Invest 93:63-69; 1994.
6. 6. Brown, J. P., Delmas, P. D., Malaval, L., Edouard, C., Chapuy, M. C., and Meunier, P. J. Serum bone Gla-protein: A specific marker for bone formation in postmenopausal osteoporosis. Lancet 1:1091-1093; 1984.
7. 7. Brown, M. S. and Goldstein, J. L. The estradiol stimulated lipoprotein receptor of rat liver. J Biol Chem 254:10454-10471; 1980.
8. 8. Bryant, H. U., Turner, C. H., Frolik, C. A., Magee, D. E., Cole, H. W., Brown, C. E., Rippy, M. R., and Sato, M. Long term effects of raloxifene (139478 HCl) on bone, cholesterol and uterus in ovariectomized rats. Bone 16(suppl.):S116; 1995.
9. 9. Chao, Y., Windier, E. E., Chen, G. C., and Havel, R. J. Hepatic catabolism of rat and human lipoproteins in rats treated with 17-alpha-ethinyl estradiol. J Biol Chem 254:11360-11366; 1979.
10. 10. Colditz, G. A., Hankinson, S. E., Hunter, D. J., Willett, W. C., Manson, J. E., Stampfer, M. J., Hennekens, C., Rosner, B., and Speizer, F. E. The use of estrogens and progestins and the risk of breast cancer in postmenopausal women. N Engl J Med 332:1589-1593; 1995.
11. 11. Delmas, P. D. Biochemical markers of bone turnover. J Bone Miner Res 8 (suppl. 2):S549-S555; 1993.
12. 12. Delmas, P.D., Schlemmer, A., Gineyts, E., Riis, B., and Christiansen, C. Urinary excretion of pyridinoline crosslinks correlates with bone turnover measured on iliac crest biopsy in patients with vertebral osteoporosis. J Bone Miner Res 6:639-644; 1991.
13. 13. Dempster, D. W., Birchman, R., Xu, R., Lindsay, R., and Shen, V. Temporal changes in cancellous bone structure of rats immediately after ovariectomy. Bone 16:157-161; 1995.
14. 14. Draper, M. W., Boss, S. M., Huster, W. J., and Neild, J. A. Effects of raloxifene hydrochloride on serum markers of bone and lipid metabolism - dose response relationships. Calcif Tissue Int 54:339; 1994.
15. 15. Eastell, R., Robins, S. P., Colwell, T., Assiri, A. M. A., Riggs, B. L., and Russell, R. G. G. Evaluation of bone turnover in type I osteoporosis using biochemical markers specific for both bone formation and bone resorption. Osteoporos Int 3:255-260; 1993.
16. 16. Evans, G., Bryant, H. U., Magee, D., Sato, M., and Turner, R. T. The effects of raloxifene on tibia histomorphometry in ovariectomized rats. Endocrinology 134:2283-2288; 1994.
17. 17. Ferreri, L. F. and Naito, H. K. Effect of estrogens on rat serum cholesterol concentrations: Consideration of dose, type of estrogen, and treatment duration. Endocrinology 102:1621-1627; 1978.
18. 18. Garnero, P., Shin, W. J., Gineyts, E., Karpf, D. B., and Delmas, P. D. Comparison of new biochemical markers of bone turnover in late postmenopausal osteoporotic women in response to alendronate therapy. J Clin Endocrinol Metab 79:1693-1700; 1994.
19. 19. Gold, E., Stapley, S., and Goulding, A. Tamoxifen and norethisterone: Effects on plasma cholesterol and total body calcium content in the estrogen-deficient rat. Horm Metab Res 26:100-103; 1994.
20. 20. Griffing, G. T. and Allen, S. H. Estrogen replacement therapy at menopause: How benefits outweigh risks. Postgrad Med 96:131-140; 1994.
21. 21. Harris, S. T., Gertz, B. J., Genant, H. K., Eyre, D. R., Survill, T. T., Ventura, J. N., DeBrock, J., Ricerca, E., and Chesnut, C. H., III. The effect of short term treatment with alendronate on vertebral density and biochemical markers of bone remodeling in early postmenopausal women. J Clin Endocrinol Metab 76:1399-1406; 1993.
22. 22. Hayward, M. A., Kharode, Y. P., Becci, M. M., and Kowal, D. The effect of conjugated equine estrogens on ovariectomy-induced osteopenia in the rat. Agents Actions 31:152-156; 1990.
23. 23. Hietala, E. L. The effect of ovariectomy on periosteal bone formation and bone resorption in adult rats. Bone Miner 20:57-65; 1993.
24. 24. Ismail, S. M. Pathology of endometrium treated with tamoxifen. J Clin Pathol 47:827-833; 1994.
25. 25. Kalu, D. N. The ovariectomized rat model of post-menopausal bone loss. Bone Miner 15:175-192; 1991.
26. 26. Kalu, D. N., Liu, C. C., Salerno, E., Hollis, B., Echon, R., and Ray, M. Skeletal response of ovariectomized rats to low and high doses of 17 beta-estradiol. Bone Miner 14:175-187; 1991.
27. 27. Kedar, R. P., Bourne, T. H., Powles, T. J., Collins, W. P., Ashley, S. E., Cosgrove, D. O., and Campbell, S. Effects of tamoxifen on uterus and ovaries of postmenopausal women in a randomized breast cancer prevention trial. Lancet 343:1318-1321; 1994.
28. 28. Moon, L. Y., Wakley, G. K., and Turner, R. T. Dose-dependent effects of tamoxifen on long bones in growing rats: Influence of ovarian status. Endocrinology 129:1568-1574; 1991.
29. 29. Prestwood, K. M., Pilbeam, C. C., Burleson, J. A., Woodiel, P. N., Delmas, P.D., Deftos, L. J., and Raisz, L. G. The short term effects of conjugated estrogen on bone turnover in older women. J Clin Endocrinol Metab 79:366-371; 1994.
30. 30. Price, P. A., Williamson, M. K., and Lothringer, J. W. Origin of the vitamin K-dependent bone protein found in plasma and its clearance by kidney and bone. J Biol Chem 256:12760-12766; 1981.
31. 31. Prockop, D. J. and Kivirikko, K. I. Relationship of hydroxyproline excretion in urine to collagen metabolism: Biochemistry and clinical applications. Ann Intern Med 66:1243-1266; 1967.
32. 32. Riggs, B. L. Overview of osteoporosis. West J Med 154:63-77; 1991.
33. 33. Riggs, B. L. and Melton, L. J., III. The prevention and treatment of osteoporosis. N Engl J Med 327:620-627; 1992.
34. 34. Robins, S. P. Crosslinking of collagen: Isolation, structural characterization and glycosylation of pyridinoline. Biochem J 215:167-173; 1983.
35. 35. Sato, M., Kim, J., Short, L. L., Slemenda, C. W., and Bryant, H. U. Longitudinal and cross-sectional analysis of raloxifene effects on tibiae from ovariectomized aged rats. J Phannacol Exp Ther 272:1252-1259; 1995.
36. 36. Sato, M., McClintock, C., Kim, J., Turner, C. H., Bryant, H. U., Magee, D., and Slemenda, C. W. Dual-energy x-ray absorptiometry of raloxifene effects on the lumbar vertebrae and femora of ovariectomized rats. J Bone Miner Res 9:715-724; 1994.
37. 37. Seedor, J. G., Quartuccio, H. A., and Thompson, D. D. The bisphosphonate alendronate (MK-217) inhibits bone loss due to ovariectomy in rats. J Bone Miner Res 6:339-346; 1991.
38. 38. Seibel, M. J., Cosman, F., Shen, V., Gordon, S., Dempster, D. W., Ratchliffe, A., and Lindsay, R. Urinary hydroxypyridinium crosslinks of collagen as markers of bone resorption and estrogen efficacy in postmenopausal osteoporosis. J Bone Miner Res 8:881-889; 1993.
39. 39. Toniolo, P. G., Levitz, M., Zeleniuch-Jacquotte, A., Banerjee, S., Koenig, K. L., Shore, R. E., Strax, P., and Pasternack, B. S. A prospective study of endogenous estrogens and breast cancer in postmenopausal women. J Natl Cancer Inst 87:190-197; 1995.
40. 40. Turner, C. H., Sato, M., and Bryant, H. U. Raloxifene preserves bone strength and bone mass in ovariectomized rats. Endocrinology 135:2001-2005; 1994.
41. 41. Turner, R. T., Evans, G. L., and Wakley, G. K. Mechanism of action of estrogen on cancellous bone balance in tibiae of ovariectomized growing rats: Inhibition of indices of formation and resorption. J Bone Miner Res 8:359-366; 1993.
42. 42. Turner, R. T., Wakley, G. K., Hannon, K. S., and Bell, N. H. Tamoxifen prevents the skeletal effects of ovarian hormone deficiency in rats. J Bone Miner Res 2:449-456; 1987.
43. 43. Uebelhart, D., Schlemmer, A., Johansen, J. S., Gineyts, E., Christiansen, C., and Delmas, P. D. Effect of menopause and hormone replacement therapy on the urinary excretion of pyridinium cross-links. J Clin Endocrinol Metab 72:367-373; 1991.
44. 44. Williams, D. C., Paul, D. C., and Black, L. J. Effects of estrogen and tamoxifen on serum osteocalcin levels in ovariectomized rats. Bone Miner 14:205-220; 1991.
45. 45. Wronski, T. J., Cintron, M., Doherty, A. L., and Dann, L. M. Estrogen treatment prevents osteopenia and depresses bone turnover in ovariectomized rats. Endocrinology 123:681-686; 1988.
46. 46. Wronski, T. J., Dann, L. M., Scott, K. S., und Cintron, M. Long-term effects of ovariectomy and aging on the rat skeleton. Calcif Tissue Int 45:360-366; 1989.
47. 47. Wronski, T. J., Dann, L. M., Scott, K. S., and Crooke, L. R. Endocrine and pharmacological suppressors of bone turnover protect against osteopenia in ovariectomized rats. Endocrinology 125:810-816; 1989.
48. 48. Wronski, T. J., Walsh, C. C., and Ignaszewski, L. A. Histologic evidence for osteopenia and increased bone turnover in ovariectomized rats. Bone 7:119-123; 1986.
49. 49. Wronski, T. J. and Yen, C.-F. The ovariectomized rat model as an animal model for postmenopausal bone loss. Cells Mater. suppl. 1:69-74; 1991.
50. 50. Wuthier, R. E. and Register, T. C. Role of alkaline phosphatase, a polyfunctional enzyme, in mineralizing tissues. The Chemistry and Biology of Mineralized Tissues. Butler, W. T., Ed. Birmingham, AL: EBSCO Media; 1985; 113-124.